Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Terminated Phase 1 Trials for Mycophenolate mofetil (DB00688)

IndicationStatusPhase
DBCOND0029923 (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02728700Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTPrevention